BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hu C, Chen X, Huang Y, Chen Y. Co-administration of iRGD with peptide HPRP-A1 to improve anticancer activity and membrane penetrability. Sci Rep 2018;8:2274. [PMID: 29396568 DOI: 10.1038/s41598-018-20715-4] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 4.8] [Reference Citation Analysis]
Number Citing Articles
1 Sahu A, Choi WI, Tae G. Recent Progress in the Design of Hypoxia-Specific Nano Drug Delivery Systems for Cancer Therapy. Adv Therap 2018;1:1800026. [DOI: 10.1002/adtp.201800026] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 6.0] [Reference Citation Analysis]
2 Hu C, Huang Y, Chen Y. Targeted Modification of the Cationic Anticancer Peptide HPRP-A1 with iRGD To Improve Specificity, Penetration, and Tumor-Tissue Accumulation. Mol Pharm 2019;16:561-72. [PMID: 30592418 DOI: 10.1021/acs.molpharmaceut.8b00854] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
3 Sultana A, Luo H, Ramakrishna S. Antimicrobial Peptides and Their Applications in Biomedical Sector. Antibiotics (Basel) 2021;10:1094. [PMID: 34572676 DOI: 10.3390/antibiotics10091094] [Reference Citation Analysis]
4 Chen X, Hu C, Zhang Y, Hao W, He X, Li Q, Huang Y, Huang Y, Chen Y. Anticancer Activity and Mechanism of Action of kla-TAT Peptide. Int J Pept Res Ther 2020;26:2285-96. [DOI: 10.1007/s10989-020-10019-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
5 Liu X, Jiang J, Meng H. Transcytosis - An effective targeting strategy that is complementary to "EPR effect" for pancreatic cancer nano drug delivery. Theranostics 2019;9:8018-25. [PMID: 31754378 DOI: 10.7150/thno.38587] [Cited by in Crossref: 52] [Cited by in F6Publishing: 45] [Article Influence: 17.3] [Reference Citation Analysis]
6 Kang S, Lee S, Park S. iRGD Peptide as a Tumor-Penetrating Enhancer for Tumor-Targeted Drug Delivery. Polymers (Basel) 2020;12:E1906. [PMID: 32847045 DOI: 10.3390/polym12091906] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
7 Hennigs JK, Matuszcak C, Trepel M, Körbelin J. Vascular Endothelial Cells: Heterogeneity and Targeting Approaches. Cells 2021;10:2712. [PMID: 34685692 DOI: 10.3390/cells10102712] [Reference Citation Analysis]
8 Wang L, Zhao X, Xia X, Zhu C, Zhang H, Qin W, Xu Y, Hang B, Sun Y, Chen S, Jiang J, Zhang G, Hu J. Inhibitory Effects of Antimicrobial Peptide JH-3 on Salmonella enterica Serovar Typhimurium Strain CVCC541 Infection-Induced Inflammatory Cytokine Release and Apoptosis in RAW264.7 Cells. Molecules 2019;24:E596. [PMID: 30736473 DOI: 10.3390/molecules24030596] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
9 Zhang P, Ma J, Zhang Q, Jian S, Sun X, Liu B, Nie L, Liu M, Liang S, Zeng Y, Liu Z. Monosaccharide Analogues of Anticancer Peptide R-Lycosin-I: Role of Monosaccharide Conjugation in Complexation and the Potential of Lung Cancer Targeting and Therapy. J Med Chem 2019;62:7857-73. [DOI: 10.1021/acs.jmedchem.9b00634] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
10 Bae Y, Joo C, Kim G, Ko KS, Huh KM, Han J, Choi JS. Cationic Oligopeptide-Functionalized Mitochondria Targeting Sequence Show Mitochondria Targeting and Anticancer Activity. Macromol Res 2019;27:1071-80. [DOI: 10.1007/s13233-019-7153-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
11 Qiao H, Zhang L, Fang D, Zhu Z, He W, Hu L, Di L, Guo Z, Wang X. Surmounting tumor resistance to metallodrugs by co-loading a metal complex and siRNA in nanoparticles. Chem Sci 2021;12:4547-56. [PMID: 34163720 DOI: 10.1039/d0sc06680j] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Vale N, Duarte D, Silva S, Correia AS, Costa B, Gouveia MJ, Ferreira A. Cell-penetrating peptides in oncologic pharmacotherapy: A review. Pharmacol Res 2020;162:105231. [PMID: 33027717 DOI: 10.1016/j.phrs.2020.105231] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
13 Rizvi SFA, Mu S, Wang Y, Li S, Zhang H. Fluorescent RGD-based pro-apoptotic peptide conjugates as mitochondria-targeting probes for enhanced anticancer activities. Biomed Pharmacother 2020;127:110179. [PMID: 32387862 DOI: 10.1016/j.biopha.2020.110179] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
14 Hadianamrei R, Tomeh MA, Brown S, Wang J, Zhao X. Rationally designed short cationic α-helical peptides with selective anticancer activity. J Colloid Interface Sci 2022;607:488-501. [PMID: 34509120 DOI: 10.1016/j.jcis.2021.08.200] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
15 Zhu J, Huang Y, Hu C, Huang Y, Chen M, He X, Zhang Y, Wang Y, Chen Y. Inhibitory Effects and Mechanism of the Combined Use of α-Helical Peptides HPRP-A1/HPRP-A2 and Chlorhexidine Acetate Against Bacterial and Fungal Biofilms. Int J Pept Res Ther 2021;27:527-42. [DOI: 10.1007/s10989-020-10102-x] [Reference Citation Analysis]
16 Yaghoubi A, Asgharzadeh F, Movaqar A, Ghazvini K, Hassanian SM, Avan A, Khazaei M, Soleimanpour S. Anticancer activity of Helicobacter pylori ribosomal protein (HPRP) with iRGD in treatment of colon cancer. J Cancer Res Clin Oncol 2021;147:2851-65. [PMID: 34117917 DOI: 10.1007/s00432-021-03683-7] [Reference Citation Analysis]
17 Yaghoubi A, Khazaei M, Ghazvini K, Movaqar A, Avan A, Hasanian SM, Soleimanpour S. Peptides with Dual Antimicrobial-Anticancer Activity Derived from the N-terminal Region of H. pylori Ribosomal Protein L1 (RpL1). Int J Pept Res Ther 2021;27:1057-67. [DOI: 10.1007/s10989-020-10150-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Zhu J, Huang Y, Chen M, Hu C, Chen Y. Functional Synergy Of Antimicrobial Peptides And Chlorhexidine Acetate Against Gram-Negative/Gram-Positive Bacteria And A Fungus In Vitro And In Vivo. Infect Drug Resist. 2019;12:3227-3239. [PMID: 31686873 DOI: 10.2147/idr.s218778] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
19 Fadeev R, Chekanov A, Solovieva M, Bezborodova O, Nemtsova E, Dolgikh N, Fadeeva I, Senotov A, Kobyakova M, Evstratova Y, Yakubovskaya R, Akatov V. Improved Anticancer Effect of Recombinant Protein izTRAIL Combined with Sorafenib and Peptide iRGD. Int J Mol Sci 2019;20:E525. [PMID: 30691192 DOI: 10.3390/ijms20030525] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
20 Dhiman N, Shagaghi N, Bhave M, Sumer H, Kingshott P, Rath SN. Selective Cytotoxicity of a Novel Trp-Rich Peptide against Lung Tumor Spheroids Encapsulated inside a 3D Microfluidic Device. Adv Biosyst 2020;4:e1900285. [PMID: 32293162 DOI: 10.1002/adbi.201900285] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
21 Yao L, Li Y, Chen H, Wen X, Pang Y, Chen Z, Guo Z, Zhang X, Wu H, Guo W. Dual Targeting of Integrin αvβ3 and Neuropilin-1 Receptors Improves Micropositron Emission Tomography Imaging of Breast Cancer. Mol Pharm 2022. [PMID: 35414180 DOI: 10.1021/acs.molpharmaceut.1c01015] [Reference Citation Analysis]
22 Pastorino F, Brignole C, Di Paolo D, Perri P, Curnis F, Corti A, Ponzoni M. Overcoming Biological Barriers in Neuroblastoma Therapy: The Vascular Targeting Approach with Liposomal Drug Nanocarriers. Small 2019;15:1804591. [DOI: 10.1002/smll.201804591] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 7.0] [Reference Citation Analysis]
23 Goyal R, Jerath G, Akhil R, Chandrasekharan A, Puppala ER, Ponneganti S, Sarma A, Naidu VGM, Santhoshkumar TR, Ramakrishnan V. Geometry encoded functional programming of tumor homing peptides for targeted drug delivery. J Control Release 2021;333:16-27. [PMID: 33722612 DOI: 10.1016/j.jconrel.2021.03.010] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]